Predictive capability of Cys112Arg single nucleotide polymorphisms of the apolipoprotein E gene in assessing the risk of immediate and early post-traumatic seizures

Cover Page

Cite item

Full Text

Abstract

This study is aimed at investigating epileptic seizures, one of the consequences of traumatic brain injury (TBI). Immediate and early post-traumatic seizures, as well as late post-traumatic epileptic seizures or post-traumatic epilepsy, can have different pathogenetic bases. The following key risk factors associated with post-traumatic epilepsy are known: duration of unconsciousness, gunshot wounds, intracranial hemorrhage, diffuse axonal injury, prolonged (more than 3 days) post-traumatic amnesia, acute subdural hematoma with surgical evacuation, immediate and early post-traumatic epileptic seizures, fracture of the skull bones. The role of genetic factors in post-traumatic seizures is poorly understood due to the complexity and multiple causal mechanisms. This paper addresses the role of genetic factors in the occurrence and severity of epileptic events in patients with TBI. In particular, we investigated the role of the Cys112Arg single nucleotide polymorphism of the apolipoprotein E gene. Apolipoprotein E is known for its role in the transport and metabolism of lipids and, therefore, the development of cardiovascular diseases; it is also associated with Alzheimer's disease and has recently been studied in the context of association with epilepsy. The study shows an association between this polymorphism and the risk of immediate and early epileptic seizures in patients with severe TBI.

About the authors

Kseniia K. Kriukova

Sechenov First Moscow State Medical University (Sechenov University)

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0001-6714-9780

аспирант каф. нервных болезней и нейрохирургии

Russian Federation, Moscow

Evgenia V. Alexandrova

Burdenko National Medical Research Center for Neurosurgery

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0001-5327-314X

канд. мед. наук, врач-невролог 

Russian Federation, Moscow

Olga N. Voskresenskaya

Sechenov First Moscow State Medical University (Sechenov University)

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0002-7330-633X

д-р мед. наук, проф. каф. нервных болезней и нейрохирургии

Russian Federation, Moscow

Vitaliy V. Podlepich

Burdenko National Medical Research Center for Neurosurgery

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0002-3424-3815

канд. мед. наук, врач-реаниматолог 

Russian Federation, Moscow

Alexander D. Kravchuk

Burdenko National Medical Research Center for Neurosurgery

Author for correspondence.
Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0002-3112-8256

д-р мед. наук, врач-нейрохирург, зав. отд-нием черепно-мозговой травмы

Russian Federation, Moscow

Eric I. Rytkin

Northwestern University

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0003-2511-0655

докторант, науч. сотр. 

United States, Chicago

Yaroslav A. Latyshev

Burdenko National Medical Research Center for Neurosurgery

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0002-7125-5962

канд. мед. наук, врач-нейрохирург

Russian Federation, Moscow

Dmitry A. Kudlay

Sechenov First Moscow State Medical University (Sechenov University)

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0003-1878-4467

чл.-кор. РАН, д-р мед. наук, проф. каф. фармакологии Института фармации им. А.П. Нелюбина 

Russian Federation, Moscow

Susanna S. Sologova

Sechenov First Moscow State Medical University (Sechenov University)

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0002-8526-7147

канд. биол. наук, доц., зав. учебной частью каф. фармакологии Института фармации им. А.П. Нелюбина 

Russian Federation, Moscow

Sabr A. Albagachiev

Sechenov First Moscow State Medical University (Sechenov University)

Email: ks.k.kryukova@gmail.com
ORCID iD: 0009-0003-5489-7001

ординатор каф. фармацевтической технологии Института фармации им А.П. Нелюбина 

Russian Federation, Moscow

Mark A. Mandrik

Sechenov First Moscow State Medical University (Sechenov University)

Email: ks.k.kryukova@gmail.com
ORCID iD: 0000-0002-3558-9615

ассистент каф. фармацевтической технологии Института фармации им. А.П. Нелюбина

Russian Federation, Moscow

References

  1. Hyder AA, Wunderlich CA, Puvanachandra P, et al. The impact of traumatic brain injuries: A global perspective. NeuroRehabilitation. 2007;22:341-53. doi: 10.3233/NRE-2007-22502
  2. Salazar AM, Grafman J. Role of Antiseizure Prophylaxis Following Head Injury. Post-traumatic epilepsy: clinical clues to pathogenesis and paths to prevention. Handb Clin Neurol. 2015;128:525-38. doi: 10.1016/B978-0-444-63521-1.00033-9
  3. Agrawal A, Timothy J, Pandit L, Manju M. Post-traumatic epilepsy: An overview. Clin Neurol Eurosurg. 2006;108:433-9. doi: 10.1016/j.clineuro.2005.09.001
  4. Cecile JW, Ioannidis JPA, Bedrosian S, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration: grips statement: explanation and elaboration. Eur J Clin Invest. 201;141:1010-35. doi: 10.1111/j.1365-2362.2011.02493.x
  5. Boone DR, Weisz HA, Willey HE, et al. Traumatic brain injury induces long-lasting changes in immune and regenerative signaling. PloS One. 2019;14. doi: 10.1371/journal.pone.0214741
  6. Jarrahi A, Braun M, Ahluwalia M, et al. Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions. Biomedicines. 2020;8:389. doi: 10.3390/biomedicines8100389
  7. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99:4-9. doi: 10.1093/bja/aem131
  8. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg. 1999;91:750-60. doi: 10.3171/jns.1999.91.5.0750
  9. Zimmermann LL, Diaz-Arrastia R, Vespa PM. Seizures and the Role of Anticonvulsants After 15. Traumatic Brain Injury. Neurosurg Clin N Am. 2016;27:499-508. doi: 10.1016/j.nec.2016.06.001
  10. Misra S, Quinn TJ, Falcone GJ, et al. Impact of genetic polymorphisms on the risk of epilepsy amongst patients with acute brain injury: A systematic review. Eur J Neurol. 2023;30:1791-800. doi: 10.1111/ene.15777
  11. Lamoureux L, Marottoli FM, Tseng KY, Tai LM. APOE4 Promotes Tonic-Clonic Seizures, an Effect Modified by Familial Alzheimer’s Disease Mutations. Front Cell Dev Biol. 2021;9:656521. doi: 10.3389/fcell.2021.656521
  12. Raulin AC, Doss SV, Trottier ZA, et al. ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72. doi: 10.1186/s13024-022-00574-4
  13. Miller MA, Conley Y, Scanlon JM, et al. APOE genetic associations with seizure development after severe traumatic brain injury. Brain Inj. 2010;24:1468-77. doi: 10.3109/02699052.2010.520299
  14. Клинические рекомендации «Очаговая травма головного мозга» (утв. Минздравом России). М., 2022 [Klinicheskie rekomendatsii “Ochagovaia travma golovnogo mozga (utv. Minzdravom Rossii). Moscow, 2022 (in Russian)].

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The odds ratio for different modes of inheritance of Cys112Arg single nucleotide polymorphism of the ApoE gene, depending on the presence of immediate and early epileptic seizures.

Download (66KB)

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies